Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 5/20 | 0.72 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.55 |
| ▸ | FAAH | O00519 | 2/20 | 0.53 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.52 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.52 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.51 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.51 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.51 |
| ▸ | ITGAV | P06756 | 1/20 | 0.51 |
| ▸ | TLR2 | O60603 | 1/20 | 0.50 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.50 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6349086 | 0.94 | CNR2 (0.73) | CNR2POLBMEN1KMT2ANOD1 | |
| SCHEMBL30444477 | 0.89 | CNR2 (0.68) | CNR2POLBMEN1KMT2ASIRT2 | |
| SCHEMBL16115188 | 0.88 | POLB (0.69) | CNR2POLBMEN1KMT2A | |
| SCHEMBL16114852 | 0.88 | POLB (0.69) | CNR2POLBMEN1KMT2A | |
| SCHEMBL15087599 | 0.85 | CNR2 (0.97) | CNR2POLBMEN1KMT2A | |
| SCHEMBL22129697 | 0.84 | ITGB3 (0.64) | CNR2ITGB3ITGAVITGA2B | |
| SCHEMBL22129699 | 0.84 | ITGB3 (0.64) | CNR2ITGB3ITGAVITGA2B | |
| SCHEMBL15064314 | 0.84 | CNR2 (1.00) | CNR2POLBMEN1KMT2A | |
| SCHEMBL1856691 | 0.83 | CNR2 (0.72) | CNR2POLBMEN1KMT2A | |
| SCHEMBL8695595 | 0.83 | CNR2 (0.72) | CNR2POLBMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025151884-A1 | USE OF GLYCOSAMINOGLYCAN SULFATED POLYSACCHARIDES SUCH AS SODIUM PENTOSAN POLYSULFATE IN COMBINATION WITH PERMEATION AGENTS TO TREAT ALZHEIMER'S DISEASE | PARSONS C LOWELL (US) | 2025-07-17 | — | — | WO | claimed |